SBI Securities Co. Ltd. Takes Position in Masimo Co. (NASDAQ:MASI)

SBI Securities Co. Ltd. acquired a new stake in Masimo Co. (NASDAQ:MASI) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 278 shares of the medical equipment provider’s stock, valued at approximately $46,000.

Several other hedge funds have also modified their holdings of MASI. FMR LLC raised its stake in shares of Masimo by 41.2% in the third quarter. FMR LLC now owns 6,756,618 shares of the medical equipment provider’s stock valued at $900,860,000 after acquiring an additional 1,970,883 shares in the last quarter. Westfield Capital Management Co. LP raised its stake in shares of Masimo by 23.2% in the third quarter. Westfield Capital Management Co. LP now owns 1,394,056 shares of the medical equipment provider’s stock valued at $185,869,000 after acquiring an additional 262,370 shares in the last quarter. Assenagon Asset Management S.A. raised its stake in shares of Masimo by 916.1% in the fourth quarter. Assenagon Asset Management S.A. now owns 216,051 shares of the medical equipment provider’s stock valued at $35,713,000 after acquiring an additional 194,788 shares in the last quarter. Clearline Capital LP acquired a new stake in Masimo in the third quarter valued at $21,337,000. Finally, ING Groep NV raised its stake in Masimo by 143.3% in the third quarter. ING Groep NV now owns 240,900 shares of the medical equipment provider’s stock valued at $32,119,000 after buying an additional 141,900 shares in the last quarter. 85.96% of the stock is currently owned by institutional investors and hedge funds.

Masimo Stock Performance

Shares of MASI stock opened at $166.52 on Wednesday. The stock’s 50-day moving average is $174.91 and its two-hundred day moving average is $156.88. The firm has a market cap of $8.98 billion, a price-to-earnings ratio of 114.84 and a beta of 1.03. Masimo Co. has a 1 year low of $101.61 and a 1 year high of $194.88. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.11 and a current ratio of 2.01.

Masimo (NASDAQ:MASI) last issued its quarterly earnings data on Tuesday, February 25th. The medical equipment provider reported $1.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.42 by $0.38. The company had revenue of $600.70 million for the quarter, compared to analyst estimates of $593.35 million. Masimo had a return on equity of 14.98% and a net margin of 3.85%. Analysts predict that Masimo Co. will post 4.1 earnings per share for the current year.

Analyst Ratings Changes

A number of research firms have weighed in on MASI. Raymond James raised their price target on Masimo from $170.00 to $194.00 and gave the company an “outperform” rating in a research note on Friday, December 27th. Wells Fargo & Company raised their price target on Masimo from $193.00 to $205.00 and gave the company an “overweight” rating in a research note on Wednesday, February 26th. Stifel Nicolaus restated a “buy” rating and issued a $190.00 price target (up from $170.00) on shares of Masimo in a research note on Friday, November 22nd. Piper Sandler raised their price target on Masimo from $210.00 to $215.00 and gave the company an “overweight” rating in a research note on Wednesday, February 26th. Finally, Needham & Company LLC restated a “hold” rating on shares of Masimo in a research note on Wednesday, February 26th. Two research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Masimo presently has an average rating of “Moderate Buy” and an average price target of $194.80.

About Masimo

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.